ArticleTrials2025

Comparison of efficacy of rifaximin, probiotics and L-ornithine L-aspartate in overt hepatic encephalopathy: a randomized, phase IV, lactulose controlled clinical trial.

Amna Shahbaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.